Sauder Schelkopf is investigating potential claims on behalf of employees and plan participants arising from the handling of prescription drug rebates in employer-sponsored health plans.
Most large employer health plans are governed by the Employee Retirement Income Security Act of 1974 (ERISA), which requires plan fiduciaries to act solely in the best interests of participants and beneficiaries. Recent regulatory changes and legal actions have focused increased attention on whether rebate arrangements involving pharmacy benefit managers (PBMs), consultants, brokers, and other service providers may conflict with those fiduciary duties.
In particular, questions have arisen as to whether rebate structures, compensation arrangements, or undisclosed financial incentives may have resulted in higher drug costs, reduced plan benefits, or increased out-of-pocket expenses for employees, rather than maximizing value for plan participants.
Sauder Schelkopf is reviewing these issues and evaluating whether certain practices may give rise to ERISA fiduciary-breach or prohibited-transaction claims, depending on the facts and circumstances of individual plans.
If you are:
- An employee or retiree enrolled in an employer-sponsored health plan, or
- An employer or plan sponsor concerned about rebate practices, PBM arrangements, or fiduciary compliance
Contact Sauder Schelkopf
If you believe you were affected or would like more information, Sauder Schelkopf offers a confidential, no-cost review.
Experience Matters
Sauder Schelkopf has a nationally recognized litigation practice. The firm currently serves as court-appointed lead counsel in courts across the country. The attorneys at Sauder Schelkopf have recovered over $1 billion on behalf of their clients and class members. Our firm was recognized by the Legal Intelligencer’s 2022 Professional Excellence Awards. The Legal Intelligencer’s Professional Excellence Awards honor Pennsylvania law firms and attorneys who have made a significant, positive impact on the legal profession. Our firm was named in the Litigation Departments of the Year (Specialty Area category; runner-up), an award that honors the best litigation practice in a small or mid-sized firm in Pennsylvania. This recognition was based on the firm’s 2021 litigation work and its important ongoing cases. LawDragon has recognized our attorneys in its list of the “500 Leading Plaintiff Consumer Lawyers” for 2022. This list notes: “From the opioid epidemic to toxic substances and defective products, truck accidents to wildfires and sexual abuse, these are the lawyers who stand on the front line in individual lawsuits and class actions seeking justice.” Mr. Schelkopf was named to Pennsylvania’s Best Lawyers® 2022 for Class Actions/Mass Tort Litigation. The American Lawyer named Mr. Sauder to its 2021 Northeast Trailblazers. The honor recognizes 60 lawyers who are “truly agents of change.” It “recognizes professionals in the Northeast who have moved the needle in the legal industry.” The Legal Intelligencer named Mr. Sauder and Mr. Schelkopf in its 2020 Pennsylvania Trailblazers list recognizing 31 lawyers who “have taken extra measures to contribute to positive outcomes . . . and who are truly agents of change.” The Legal highlighted the firm’s innovative work on advocacy as class counsel in large institutional sex abuse cover-ups, women’s, and children’s rights. Our attorneys have also consistently been recognized by their peers being named to Pennsylvania SuperLawyer, a distinction held by the top 5% of attorneys in Pennsylvania. The National Trial Lawyers Association has also selected our attorneys as the Top 100 Trial Lawyers in Pennsylvania.
We Want to Hear from You
If you think this conduct has impacted you, please fill out the form on this page to contact the attorneys at Sauder Schelkopf, a leading class action law firm, to learn more about your legal rights and options.